期刊文献+

氧化应激与非酒精性脂肪性肝病研究进展 被引量:30

Progress in research of oxidative stress and non-alcoholic fatty liver disease
下载PDF
导出
摘要 非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)是一种遗传-环境-代谢应激相关性疾病,其发病机制尚未完全明确,其中氧化应激对于NAFLD的发生发展起着关键作用.本文对NAFLD与氧化应激及其相关影响因素(如线粒体、微粒体、脂质过氧化、解偶联蛋白-2)作一综述. Non-alcoholic fatty liver disease (NAFLD) is a genetic-environmental-metabolic stress related disease, with its pathogenesis not completely elucidated, whereas oxidative stress plays a major role in the occurrence and development of NAFLD. This article provides a brief review on the role of oxidative stress in NAFLD and its related factors such as the mitochondria, microsomes, lipid peroxidation and uncoupling protein -2.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第9期896-900,共5页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 No.30772802 上海市教委重点学科基金资助项目 No.J50305~~
关键词 非酒精性脂肪性肝病 氧化应激 活性氧 Non-alcoholic fatty liver disease Oxida-tive stress Reactive oxygen species
  • 相关文献

参考文献31

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1511
  • 2Brunt EM. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Semin Diagn Pathol 2005; 22:330-338.
  • 3曾民德.脂肪性肝病的氧应激及其治疗对策[J].国外医学(消化系疾病分册),2005,25(5):263-266. 被引量:15
  • 4Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 2001; 21:57-69.
  • 5McKenzie M, Liolitsa D, Hanna MG. Mitochondrial disease: mutations and mechanisms. Neurochem Res 2004; 29:589-600.
  • 6Serviddio G, Sastre J, Bellanti F, Vina J, Vendemiale G, Altomare E. Mitochondrial involvement in non- alcoholic steatohepatitis. Mol Aspects Med 2008; 29: 22-35.
  • 7Kojirna H, Sakurai S, Uemura M, Fukui H,Morimoto H, Tamagawa Y. Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis. Alcohol Clin Exp Res 2007; 31: S61-S66.
  • 8Perez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martin A, Castellano G, Colina F, Arenas J, Solis-Herruzo JA. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003; 38:999-1007.
  • 9Petrosillo G, Portincasa P, Grattagliano I, Casanova G, Matera M, Ruggiero FM, Ferri D, Paradies G. Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochim Biophys Acta 2007; 1767:1260-1267.
  • 10Hayashi S, Yasui H, Sakurai H. Essential role of singlet oxygen species in cytochrome P450- dependent substrate oxygenation by rat liver microsornes, Drug Metab Pharmacokinet 2005; 20: 14-23.

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1522

同被引文献380

引证文献30

二级引证文献188

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部